Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study.

Saved in:
Bibliographic Details
Title: Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study.
Authors: Weng CH; Department of Family Medicine, Brown University Warren Alpert Medical School, Providence, RI, 02912, USA. chien-hsiang_weng@brown.edu.; Bio Med Family Medicine, Brown University, Box G-MHRI, Providence, RI, 02912, USA. chien-hsiang_weng@brown.edu., Chan PA; Department of Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA., Magagnoli J; Southern Network on Adverse Reactions (SONAR) program, Department of Clinical Pharmacy Outcomes Sciences, The University of South Carolina College of Pharmacy, Columbia, SC, USA., Bennett CL; Southern Network on Adverse Reactions (SONAR) program, Department of Clinical Pharmacy Outcomes Sciences, The University of South Carolina College of Pharmacy, Columbia, SC, USA.
Source: Drug safety [Drug Saf] 2026 Feb; Vol. 49 (2), pp. 253-254. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Letter; Comment
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1179-1942
DOI:10.1007/s40264-025-01617-7